KAM
AMRI

Kassirer Asset Management’s Albany Molecular Research Inc AMRI Stock Holding History

Kassirer Asset Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-181,394
Closed -$3.94M – 85
2017
Q2 		$3.94M Buy
+181,394
New +$3.29M 2.85% 12

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Kassirer Asset Management's AMRI Position: Q3 2017 in Review

Kassirer Asset Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 181,394 shares — an estimated $3.94M sold.

Kassirer Asset Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $3.94M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Kassirer Asset Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Kassirer Asset Management sold 181,394 Albany Molecular Research Inc shares in Q3 2017, an estimated $3.94M.
  • Kassirer Asset Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Kassirer Asset Management's Albany Molecular Research Inc position peaked at $3.94M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Kassirer Asset Management's 13F filing for Q3 2017, filed 6 Nov 2017.